Day: February 11, 2025

Enforcement of Intellectual Property Remains Priority for Advancement of US Solar Industry PORTLAND, Tenn., Feb. 11, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (Shoals) (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today that it has filed a Petition for Review and Notice of Appeal to the United States Court of Appeals for the Federal Circuit. The appeal seeks review of the International Trade Commission (ITC) decision to reverse the Administrative Law Judge’s (ALJ) prior determination that Voltage’s LYNX trunk bus products infringe Shoals’ ’153 Patent. In the filing, Shoals requests that the Federal Circuit Court of Appeals review and overturn the ITC’s interpretation of the Shoals ’153 Patent. The review would be on a “de novo” basis, meaning...

Tel Aviv, Israel, Feb. 11, 2025 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “Company or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense Counter UAS systems, today announces preliminary unaudited results for the year ended December 31, 2024. The Company’s revenues for the year ended December 31, 2024 are expected to increase by approximately 45% and are expected to amount to approximately $900,000, compared to revenues of approximately $620,000 in the year ended December 31, 2023. As of December 31, 2024, the Company had cash and cash equivalents of approximately $4.2 million, compared to approximately $7.4 million on December 31, 2023. This unaudited preliminary and partial financial information regarding revenues for the year ended December 31,...

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of 6,103,289 shares of the Company’s common stock at a purchase price of $2.13 per share of common stock. In addition, in a concurrent private placement, the Company issued unregistered short-term series I preferred investment options. The short-term series I preferred investment options to purchase up to 12,206,578 shares of common stock have an exercise price of $2.13 per share and will be exercisable for a period of two years beginning on the later of (i) the effective date of the increase of the Company’s authorized shares of common stock following stockholder approval and (ii) the effective...

TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that at January 31, 2025, its unaudited net asset value per share (“NAV”) was $0.60.   This announcement is made based on ThreeD’s established practice of releasing NAV on a monthly basis as part of the Company’s ongoing response to shareholder interest in receiving periodic information. NAV is calculated based on unaudited month-end financial information. Use of Non-GAAP Financial Measures: This press release contains references to NAV or “net asset value per share” which is a non-GAAP financial measure. NAV is calculated as the value of total assets less the...

TORONTO, Feb. 11, 2025 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) (the “Company”) is pleased to announce it has closed its previously announced offering of 5.25% convertible senior notes due 2030 (the “Notes”) in an aggregate principal amount of $110 million (the “Offering”), which includes the upsized offering of $95 million and the exercise in full of the $15 million option granted to the initial purchasers of the Notes. All amounts are in United States Dollars. The initial conversion rate for the Notes is 88.9284 shares of the Company’s common stock per $1,000 principal amount of Notes, equivalent to an initial conversion price of approximately $11.25 per share, which represents a premium of approximately 30% to the closing sale price of the Company’s common stock on February 6th, 2025; the capped call(1) has...

GOMEKLI™ (mirdametinib) capsules and tablets for oral suspensionGOMEKLI™ (mirdametinib) capsules and tablets for oral suspensionSaqib Islam, SpringWorks Therapeutics CEOSaqib Islam, SpringWorks Therapeutics CEOSpringWorks Therapeutics, IncSpringWorks Therapeutics, Inc.GOMEKLI™ (mirdametinib) logoGOMEKLI™ (mirdametinib) logo– GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on positive data from Phase 2b ReNeu trial, which showed GOMEKLI treatment resulted in robust ORR, deep and durable reductions in tumor volume, and a manageable safety profile – – SpringWorks granted rare pediatric disease priority review voucher by the FDA – Photos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/8eb8effc-49a5-4b24-911f-d3e6dfa9c8a9https://www.globenewswire.com/NewsRoom/AttachmentNg/f1041678-3f79-43b7-a101-2390fb8cb86bhttps://www.globenewswire.com/NewsRoom/AttachmentNg/7d8cb318-e5f8-4944-8736-24cb19a5dec9https://www.globenewswire.com/NewsRoom/AttachmentNg/072d748b-3237-48ad-8d83-1c6c23dda65f STAMFORD,...

HAMILTON, Bermuda, Feb. 11, 2025 (GLOBE NEWSWIRE) — Teekay Corporation Ltd. (Teekay) (NYSE:TK) and Teekay Tankers Ltd. (Teekay Tankers) (NYSE:TNK) (collectively, the Teekay Group) plan to release their financial results for the fourth quarter and annual 2024 after market close on Wednesday, February 19, 2025. The Teekay Group plans to host a conference call on Thursday, February 20, 2025 at 11:00 a.m. (ET) to discuss its results for the fourth quarter and annual 2024. All shareholders and interested parties are invited to listen to the live conference call by choosing from the following options:By dialing 1(800) 289-0438, or 1(647) 484-0478 if outside of North America, and quoting conference ID code 5649868. By accessing the webcast, which will be available on the Teekay Group’s website at www.teekay.com (the archive will remain...